dc.contributor |
Sakagami, Hiroshi |
|
dc.date |
2022-06-21T09:07:41Z |
|
dc.date |
2022-06-21T09:07:41Z |
|
dc.date |
2022 |
|
dc.date.accessioned |
2023-02-18T19:29:35Z |
|
dc.date.available |
2023-02-18T19:29:35Z |
|
dc.identifier |
ONIX_20220621_9783036536859_28 |
|
dc.identifier |
https://directory.doabooks.org/handle/20.500.12854/84594 |
|
dc.identifier |
https://mdpi.com/books/pdfview/book/5576 |
|
dc.identifier |
https://mdpi.com/books/pdfview/book/5576 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/249667 |
|
dc.description |
With the development of analytical instruments, the academic system has become more complicated, producing new journals one after another. Therefore, it became much important to clarify what is original of “Medicines”. As the name Medicines indicates, it includes science and practice of caring for a patient and managing the diagnosis, prognosis, prevention, treatment or palliation of their injury or disease. Therefore, Medicines differs from other journals with similar title in that it covers a wide range of fields, from traditional medicine to rapidly developing molecular-targeted drugs, focusing on their pharmacological effects, structure–activity relationships, metabolic pathways, gene expression, using cultured cells, animals, and clinical trials. Most parts of this Special Issue were written by our editorial board members, who described the research topics and how they are engaged in their field of research. All of these articles are their life-long story. We collected a total number of 22 original works by basic researchers and clinical doctors. We hope that readers can get a chance to know the current status of diverse fields of medicines, and what your most important research themes are after reading these articles. |
|
dc.format |
application/octet-stream |
|
dc.language |
eng |
|
dc.publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
|
dc.rights |
open access |
|
dc.subject |
Hedychium |
|
dc.subject |
traditional medicine |
|
dc.subject |
coronarin D |
|
dc.subject |
villosin |
|
dc.subject |
anti-acetylcholinesterase |
|
dc.subject |
antidiabetic |
|
dc.subject |
anti-inflammatory |
|
dc.subject |
antimicrobial |
|
dc.subject |
antioxidant |
|
dc.subject |
antitumor |
|
dc.subject |
Genista tridentata |
|
dc.subject |
Pterospartum tridentatum |
|
dc.subject |
isoflavones |
|
dc.subject |
flavonols |
|
dc.subject |
genistein |
|
dc.subject |
biochanin A |
|
dc.subject |
rutin |
|
dc.subject |
daidzein |
|
dc.subject |
inflammatory bowel disease |
|
dc.subject |
Crohn’s disease |
|
dc.subject |
ulcerative colitis |
|
dc.subject |
extra-intestinal manifestations |
|
dc.subject |
orofacial granulomatosis |
|
dc.subject |
tag-like lesions |
|
dc.subject |
cobblestoning |
|
dc.subject |
mucogingivitis |
|
dc.subject |
lip swelling |
|
dc.subject |
aphthous stomatitis |
|
dc.subject |
Angelicae Sinensis Radix |
|
dc.subject |
Danggui |
|
dc.subject |
granules |
|
dc.subject |
herb |
|
dc.subject |
multivariate analysis |
|
dc.subject |
ultra-performance liquid chromatography |
|
dc.subject |
Tai Chi |
|
dc.subject |
qigong |
|
dc.subject |
immune system |
|
dc.subject |
immunity |
|
dc.subject |
inflammation |
|
dc.subject |
telemedicine |
|
dc.subject |
remote monitoring |
|
dc.subject |
GER-e-TEC |
|
dc.subject |
elderly patient |
|
dc.subject |
artificial intelligence |
|
dc.subject |
geriatric syndromes |
|
dc.subject |
detection of the precursory signs of decompensation of geriatric syndromes |
|
dc.subject |
renal cell cancer |
|
dc.subject |
genomic landscape |
|
dc.subject |
targeted therapy |
|
dc.subject |
tumor evolution |
|
dc.subject |
tumor heterogeneity |
|
dc.subject |
allergic rhinitis |
|
dc.subject |
quercetin |
|
dc.subject |
human CD4+ T cells |
|
dc.subject |
Th1/Th2 cytokine balance |
|
dc.subject |
modulation |
|
dc.subject |
in vitro |
|
dc.subject |
intravascular catheter |
|
dc.subject |
CRBSI |
|
dc.subject |
biofilm |
|
dc.subject |
CVC |
|
dc.subject |
antifouling |
|
dc.subject |
chromone |
|
dc.subject |
tumor specificity |
|
dc.subject |
QSAR analysis |
|
dc.subject |
apoptosis |
|
dc.subject |
cell cycle analysis |
|
dc.subject |
contrast-enhanced ultrasound |
|
dc.subject |
hepatocellular carcinoma |
|
dc.subject |
LI-RADS |
|
dc.subject |
chronic liver disease |
|
dc.subject |
granuloma annulare |
|
dc.subject |
granulomatous disorders of the skin |
|
dc.subject |
inflammatory skin conditions |
|
dc.subject |
medical dermatology |
|
dc.subject |
biliary tract cancer |
|
dc.subject |
cholangiocarcinoma |
|
dc.subject |
PARP |
|
dc.subject |
BRCA |
|
dc.subject |
olaparib |
|
dc.subject |
rucaparib |
|
dc.subject |
liver cancer |
|
dc.subject |
pancreatic adenocarcinoma |
|
dc.subject |
pancreatic cancer |
|
dc.subject |
sarcoidosis |
|
dc.subject |
superior vena cava syndrome |
|
dc.subject |
venous thrombosis |
|
dc.subject |
RUCAM |
|
dc.subject |
Roussel Uclaf Causality Assessment Method |
|
dc.subject |
diagnostic algorithm |
|
dc.subject |
iDILI |
|
dc.subject |
iDrug induced liver injury |
|
dc.subject |
DILI |
|
dc.subject |
HILI |
|
dc.subject |
herb induced liver injury |
|
dc.subject |
Stachys L. |
|
dc.subject |
traditional uses |
|
dc.subject |
pharmacological activities |
|
dc.subject |
phytochemicals |
|
dc.subject |
bioactive compounds |
|
dc.subject |
Kampo formulae |
|
dc.subject |
alkaline extract of Sasa sp. |
|
dc.subject |
pine cone extract |
|
dc.subject |
povidone-iodine |
|
dc.subject |
HSV |
|
dc.subject |
HIV |
|
dc.subject |
loss of infectivity |
|
dc.subject |
solubilization method |
|
dc.subject |
diaphragmatic breathing |
|
dc.subject |
abdominal breathing |
|
dc.subject |
breathing exercise |
|
dc.subject |
systematic review |
|
dc.subject |
randomized controlled trial |
|
dc.subject |
respiratory function |
|
dc.subject |
auricular acupuncture |
|
dc.subject |
preoperative anxiety |
|
dc.subject |
protocol |
|
dc.subject |
randomized controlled trials |
|
dc.subject |
meta-analysis |
|
dc.subject |
boiogito |
|
dc.subject |
knee osteoarthritis |
|
dc.subject |
rat |
|
dc.subject |
Yokukansan |
|
dc.subject |
fentanyl |
|
dc.subject |
transient receptor potential ankyrin 1 (TRPA1) channel |
|
dc.subject |
phosphorylated extracellular signal-regulated kinase (pERK) |
|
dc.subject |
whole-cell patch-clamp recording |
|
dc.subject |
herbal medicine |
|
dc.subject |
calcium metabolism |
|
dc.subject |
bone metabolism |
|
dc.subject |
protease |
|
dc.subject |
osteoclast |
|
dc.subject |
macrophage |
|
dc.subject |
RANKL |
|
dc.subject |
LPS |
|
dc.subject |
TLR4 |
|
dc.subject |
TREM2 |
|
dc.subject |
bic Book Industry Communication::M Medicine |
|
dc.title |
Research Topics in Medicines and How Our Board Members Are Engaged in Them |
|
dc.resourceType |
book |
|
dc.alternateIdentifier |
9783036536859 |
|
dc.alternateIdentifier |
9783036536866 |
|
dc.alternateIdentifier |
10.3390/books978-3-0365-3686-6 |
|
dc.licenseCondition |
Attribution 4.0 International |
|
dc.identifierdoi |
10.3390/books978-3-0365-3686-6 |
|
dc.relationisPublishedBy |
46cabcaa-dd94-4bfe-87b4-55023c1b36d0 |
|
dc.relationisbn |
9783036536859 |
|
dc.relationisbn |
9783036536866 |
|
dc.pages |
480 |
|